---
title: "600488.SH (600488.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600488.SH/news.md"
symbol: "600488.SH"
name: "600488.SH"
parent: "https://longbridge.com/en/quote/600488.SH.md"
datetime: "2026-05-20T19:59:28.485Z"
locales:
  - [en](https://longbridge.com/en/quote/600488.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600488.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600488.SH/news.md)
---

# 600488.SH (600488.SH) — Related News

### [Dragon and Tiger List | TJPC (600488) fell 4.91%, with the top 5 buyers purchasing a total of 228 million yuan, and the top 5 sellers selling a total of 150 million yuan. Reason for being listed: Non-ST, *ST, and S securities have accumulated a closing price drop deviation of 20% over three consecutive trading days](https://longbridge.com/en/news/286891690.md)
*2026-05-19T10:06:33.000Z*
> TJPC (600488) fell 4.91% on May 19, closing at 6 yuan, with a circulating market value of 6.551 billion yuan. The buying

### [](https://longbridge.com/en/news/286697840.md)
*2026-05-18T01:41:43.000Z*
> The A-share innovative drug sector weakened at the beginning of the trading session, TJPC hit the limit down, BEONE MEDI

### [The stock price of TJPC has soared, severely diverging from its fundamentals: performance continues to weaken, making it difficult to sustain short-term market conditions](https://longbridge.com/en/news/286496470.md)
*2026-05-15T02:05:38.000Z*
> TJPC's stock price hit the daily limit from May 11 to 12, with a cumulative increase of over 90%. However, the company's

### [](https://longbridge.com/en/news/286037190.md)
*2026-05-12T05:05:45.000Z*
> Selective movements in A-share innovative drug stocks: TJPC hit the daily limit in the afternoon, Hengrui Pharma rose ov

### [Non-recurring gains and losses drag down TJPC's performance with a "double decline"](https://longbridge.com/en/news/285816522.md)
*2026-05-09T15:00:13.000Z*
> TJPC released its 2025 annual report and the first quarter report for 2026, showing that the revenue for 2025 was 2.908 

### ["A-Share Focus" Pharmaceutical leader reports good performance, drug stocks boosted, Asymchem hits the upper limit](https://longbridge.com/en/news/284295925.md)
*2026-04-28T02:04:00.000Z*
> Pharmaceutical leader WuXi AppTec released its first-quarter report, with revenue of 12.436 billion yuan, a year-on-year

### [TJPC: Net profit in the first quarter was 13.8913 million yuan, a year-on-year decrease of 76.07%](https://longbridge.com/en/news/283978501.md)
*2026-04-24T10:13:16.000Z*
> TJPC announced that its revenue for the first quarter of 2026 was 608 million yuan, a year-on-year decrease of 22.61%; n

### [TJPC: Net profit of 70.5644 million yuan in 2025, a year-on-year decrease of 47.12%](https://longbridge.com/en/news/283978473.md)
*2026-04-24T10:13:08.000Z*
> TJPC announced that the operating revenue in 2025 is 2.908 billion yuan, a year-on-year decrease of 9.56%. The net profi

### [The innovative drug sector has seen a short-term decline, with TJPC falling over 7%](https://longbridge.com/en/news/282920095.md)
*2026-04-16T01:39:33.000Z*
> The innovative drug sector has seen a short-term decline, with TJPC falling over 7%, and companies such as Xinlitai, Shu